SARS-CoV-2 Vaccine Development: Current Status
SARS-CoV-2 Vaccine Development: Current Status
About this item
Full title
Author / Creator
Publisher
England: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
In the midst of the severe acute respiratory syndrome coronavirus 2 pandemic and its attendant morbidity and mortality, safe and efficacious vaccines are needed that induce protective and long-lived immune responses. More than 120 vaccine candidates worldwide are in various preclinical and phase 1 to 3 clinical trials that include inactivated, live...
Alternative Titles
Full title
SARS-CoV-2 Vaccine Development: Current Status
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7392072
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7392072
Other Identifiers
ISSN
0025-6196
E-ISSN
1942-5546
DOI
10.1016/j.mayocp.2020.07.021
